DVA DaVita Inc. Common Stock
$179,34
Fiyat · Ağu 18, 2026
Temel veriler itibarıyla Ağu 4, 2026
52 Haftlık Aralık
$101–$247
53% of range
Analist Derecelendirmesi
HOLD
13 analysts
Fiyat Hedefi
$218
+22% upside
P/E (TTM)
18.4
ROE
-281.8%
Net Kâr Marjı
5.5%
DaVita Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
Devamını oku
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language), incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients (36% of the total of 557,000 patients in the U.S.), and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.
History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
Acquisitions and divestments
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
Legal issues
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
DVA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$179.34
Piyasa Değeri
$12.41B
P/E (TTM)
18.4
EPS (TTM)
$9.84
Gelir (TTM)
$13.64B
Temettü Verimi
0.00%
ROE
-281.8%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$101 – $247
DVA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$13.64B
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$9.84
2016-12-31
→
2025-12-31
Serbest Nakit Akışı
$1.31B
2016-12-31
→
2025-12-31
Marjlar
5.5%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
DVA
Akran Ortalaması
P/E (TTM)
18.4
32.6
P/S (TTM) (F/S (TTM))
0.9
2.0
P/B (F/D)
-19.1
4.4
Price / FCF (Fiyat / Serbest Nakit Akışı)
9.5
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
DVA
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
15.0%
—
Net Profit Margin (Net Kâr Marjı)
5.5%
2.4%
ROA
4.3%
4.5%
ROE
-281.8%
10.9%
ROIC
-245.6%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
DVA
Akran Ortalaması
Current Ratio (Cari Oran)
1.3
1.7
Quick Ratio (Cari Oran)
1.0
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
DVA
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
6.5%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
5.5%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
3.4%
—
EPS YoY (EPS YB)
-8.3%
—
Net Income YoY (Net Gelir Yıllık Bazda)
-20.2%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
DVA
Akran Ortalaması
Payout Ratio (Temettü Ödeme Oranı)
0.00%
—
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi
0.00%
Temettü Ödeme Oranı
0.00%
5 Yıllık Temettü CAGR
—
DVA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
TUT
13 analist
- Güçlü Al 1 7,7%
- Al 5 38,5%
- Tut 6 46,2%
- Sat 1 7,7%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
7 analist · 2026-08-16
Medyan
$220.00
Şimdi
$179.34
Düşük
$165.00
Yüksek
$270.00
Medyan hedef
$220.00
+22,7%
Ortalama hedef
$218.43
+21,8%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.04%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $4.02 | $3.92 | 0.10% |
| 31 Mart 2026 | $2.87 | $2.34 | 0.53% |
| 31 Aralık 2025 | $3.40 | $3.19 | 0.21% |
| 30 Eylül 2025 | $2.04 | $3.25 | -1.2% |
| 30 Haziran 2025 | $2.95 | $2.83 | 0.12% |
| 31 Mart 2025 | $2.00 | $1.97 | 0.03% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Bilanço 27
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Nakit Akışı 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Kârlılık 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Büyüme Oranları 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | -153,159,000 | 72,075,000 | 75,943,000 | 79,368,000 | -173,404,000 | 83,721,000 | 86,899,000 | 87,775,000 | -182,013,000 | 91,322,000 | 90,984,000 | 90,497,000 | -188,967,000 | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | -156,521,000 | 73,769,000 | 77,362,000 | 81,275,000 | -178,018,000 | 85,795,000 | 88,950,000 | 90,547,000 | -186,760,000 | 94,041,000 | 93,418,000 | 92,483,000 | -195,704,000 | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Bilanço 26
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Nakit Akışı 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Değerleme (TTM) 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.77B | $13.44B | · | $13.29B | $13.05B | $12.74B | · | $12.64B | $12.38B | $12.06B | · | $11.94B | $11.75B | $11.57B | · | $11.63B | |
| Net Income TTM | $813M | $710M | · | $727M | $800M | $840M | · | $924M | $888M | $781M | · | $646M | $624M | $608M | · | $752M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 19.3 | 16.2 | · | 14.6 | 14.9 | 15.9 | · | 16.0 | 14.3 | 16.4 | · | 13.7 | 15.2 | 12.9 | · | 11.2 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.0 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| P / FCF | · | 48.6 | · | · | · | 321.7 | · | · | · | -48.5 | · | · | · | 23.4 | · | · | |
| Earnings Yield | 5.2% | 6.2% | · | 6.9% | 6.7% | 6.3% | · | 6.3% | 7.0% | 6.1% | · | 7.3% | 6.6% | 7.8% | · | 8.9% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Faaliyet Kâr Marjı % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Net Gelir | $747M | $936M | $692M | $560M | $978M |
| Seyreltilmiş Hisse Başı Kâr | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Cari Oran | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 696 dosya · $7.9B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 131 (-1 önceki Ç'ye göre) | 59 (-5 önceki Ç'ye göre) | 184 (+11 önceki Ç'ye göre) | 217 (+12 önceki Ç'ye göre) | +3.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $3.331.328.308 | 14.973.608 | 42,04% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $467.525.034 | 2.101.425 | 5,90% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306.558.307 | 1.377.914 | 3,87% | Hisse senetleri |
| STATE STREET CORP | $294.345.267 | 1.323.019 | 3,71% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $235.869.514 | 1.060.183 | 2,98% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $199.315.922 | 896.621 | 2,52% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197.802.963 | 889.082 | 2,50% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $165.824.664 | 746.907 | 2,09% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163.166.832 | 733.400 | 2,06% | Alım opsiyonu |
| Gates Capital Management, Inc. | $153.096.497 | 688.136 | 1,93% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $133.302.007 | 599.164 | 1,68% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81.331.791 | 365.569 | 1,03% | Hisse senetleri |
| NORGES BANK | $76.627.007 | 344.422 | 0,97% | Hisse senetleri |
| NORDEA INVESTMENT MANAGEMENT AB | $67.404.554 | 305.067 | 0,85% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $63.752.756 | 286.555 | 0,80% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $62.040.995 | 278.861 | 0,78% | Hisse senetleri |
| JANE STREET GROUP, LLC | $53.573.184 | 240.800 | 0,68% | Alım opsiyonu |
| Holocene Advisors, LP | $52.875.709 | 237.665 | 0,67% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.100.176 | 216.200 | 0,61% | Satım opsiyonu |
| Quantinno Capital Management LP | $45.366.106 | 203.910 | 0,57% | Hisse senetleri |
| CITADEL ADVISORS LLC | $44.465.298 | 199.862 | 0,56% | Hisse senetleri |
| CITADEL ADVISORS LLC | $44.184.528 | 198.600 | 0,56% | Alım opsiyonu |
| VANGUARD FIDUCIARY TRUST CO | $40.134.502 | 180.396 | 0,51% | Hisse senetleri |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37.089.700 | 241.328 | 0,47% | Hisse senetleri |
| Gotham Asset Management, LLC | $36.393.278 | 163.580 | 0,46% | Hisse senetleri |
| JANE STREET GROUP, LLC | $35.774.784 | 160.800 | 0,45% | Satım opsiyonu |
| Doma Perpetual Capital Management LLC | $35.522.937 | 159.668 | 0,45% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $34.161.205 | 153.548 | 0,43% | Hisse senetleri |
| TODD ASSET MANAGEMENT LLC | $32.697.663 | 146.969 | 0,41% | Hisse senetleri |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32.011.312 | 143.884 | 0,40% | Hisse senetleri |
| Allianz Asset Management GmbH | $30.236.367 | 135.906 | 0,38% | Hisse senetleri |
| MORGAN STANLEY | $28.624.054 | 128.659 | 0,36% | Hisse senetleri |
| Toroso Investments, LLC | $28.283.664 | 248.954 | 0,36% | Hisse senetleri |
| CANADA PENSION PLAN INVESTMENT BOARD | $26.480.460 | 119.024 | 0,33% | Hisse senetleri |
| BlackRock, Inc. | $26.457.544 | 118.921 | 0,33% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $26.377.896 | 118.563 | 0,33% | Hisse senetleri |
| Amundi | $25.967.198 | 116.717 | 0,33% | Hisse senetleri |
| BARCLAYS PLC | $25.933.826 | 116.567 | 0,33% | Hisse senetleri |
| Davidson Kempner Capital Management LP | $25.162.043 | 113.098 | 0,32% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $23.582.658 | 105.999 | 0,30% | Hisse senetleri |
| VANGUARD GROUP INC | $23.117.136 | 203.478 | 0,29% | Hisse senetleri |
| RHUMBLINE ADVISERS | $23.076.629 | 103.725 | 0,29% | Hisse senetleri |
| Woodline Partners LP | $22.872.501 | 102.807 | 0,29% | Hisse senetleri |
| UBS Group AG | $20.846.376 | 93.700 | 0,26% | Satım opsiyonu |
| MILLENNIUM MANAGEMENT LLC | $20.579.400 | 92.500 | 0,26% | Satım opsiyonu |
| FMR LLC | $20.183.608 | 90.721 | 0,25% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $19.532.854 | 87.796 | 0,25% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $17.151.873 | 77.094 | 0,22% | Hisse senetleri |
| California Public Employees Retirement System | $15.370.253 | 69.086 | 0,19% | Hisse senetleri |
| Swiss National Bank | $14.906.160 | 67.000 | 0,19% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $14.696.806 | 66.059 | 0,19% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $14.482.431 | 110.900 | 0,18% | Satım opsiyonu |
| National Philanthropic Trust | $14.000.889 | 62.931 | 0,18% | Hisse senetleri |
| PineBridge Investments, L.P. | $13.874.153 | 104.419 | 0,18% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $13.325.440 | 59.895 | 0,17% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $13.022.644 | 58.534 | 0,16% | Hisse senetleri |
| Candriam S.C.A. | $12.727.615 | 57.263 | 0,16% | Hisse senetleri |
| DANSKE BANK A/S | $12.471.116 | 56.055 | 0,16% | Hisse senetleri |
| CITADEL ADVISORS LLC | $12.280.896 | 55.200 | 0,15% | Satım opsiyonu |
| Susquehanna Portfolio Strategies, LLC | $12.219.714 | 54.925 | 0,15% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $11.902.680 | 53.500 | 0,15% | Alım opsiyonu |
| STOREBRAND ASSET MANAGEMENT AS | $11.500.659 | 51.693 | 0,15% | Hisse senetleri |
| LPL Financial LLC | $10.778.934 | 48.449 | 0,14% | Hisse senetleri |
| Robeco Institutional Asset Management B.V. | $10.083.684 | 45.324 | 0,13% | Hisse senetleri |
| Callahan Advisors, LLC | $10.033.403 | 45.098 | 0,13% | Hisse senetleri |
| Assenagon Asset Management S.A. | $9.963.322 | 44.783 | 0,13% | Hisse senetleri |
| Verition Fund Management LLC | $9.740.174 | 43.780 | 0,12% | Hisse senetleri |
| Prospera Financial Services Inc | $9.482.479 | 42.623 | 0,12% | Hisse senetleri |
| Te Ahumairangi Investment Management Ltd | $9.480.318 | 42.612 | 0,12% | Hisse senetleri |
| SEI INVESTMENTS CO | $9.251.830 | 41.585 | 0,12% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $9.207.557 | 41.386 | 0,12% | Hisse senetleri |
| Inlet Private Wealth, LLC | $9.004.878 | 40.475 | 0,11% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $8.835.126 | 39.712 | 0,11% | Hisse senetleri |
| Caisse de depot et placement du Quebec | $8.721.216 | 39.200 | 0,11% | Hisse senetleri |
| Twin Tree Management, LP | $8.454.240 | 38.000 | 0,11% | Alım opsiyonu |
| Brevan Howard Capital Management LP | $8.343.000 | 37.500 | 0,11% | Alım opsiyonu |
| CITIGROUP INC | $8.298.504 | 37.300 | 0,10% | Satım opsiyonu |
| NISA INVESTMENT ADVISORS, LLC | $7.947.431 | 35.722 | 0,10% | Hisse senetleri |
| IEQ CAPITAL, LLC | $7.900.154 | 35.510 | 0,10% | Hisse senetleri |
| UBS Group AG | $7.386.336 | 33.200 | 0,09% | Alım opsiyonu |
| Counterpoint Mutual Funds LLC | $7.384.111 | 33.190 | 0,09% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $7.170.308 | 32.229 | 0,09% | Hisse senetleri |
| FIFTH THIRD BANCORP | $7.074.159 | 31.797 | 0,09% | Hisse senetleri |
| Summit Trail Advisors, LLC | $7.043.272 | 31.658 | 0,09% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $6.953.397 | 45.243 | 0,09% | Hisse senetleri |
| Corient Private Wealth LP | $6.916.838 | 31.117 | 0,09% | Hisse senetleri |
| Tredje AP-fonden | $6.780.968 | 30.479 | 0,09% | Hisse senetleri |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $6.656.824 | 29.921 | 0,08% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6.539.132 | 29.392 | 0,08% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.407.202 | 28.799 | 0,08% | Hisse senetleri |
| NATIONAL BANK OF CANADA /FI/ | $6.204.782 | 27.888 | 0,08% | Hisse senetleri |
| Walleye Capital LLC | $6.184.944 | 27.800 | 0,08% | Alım opsiyonu |
| GHP Investment Advisors, Inc. | $6.107.487 | 39.739 | 0,08% | Hisse senetleri |
| Wakefield Asset Management LLLP | $5.893.051 | 26.488 | 0,07% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $5.749.551 | 25.843 | 0,07% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $5.566.805 | 36.221 | 0,07% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $5.507.937 | 24.757 | 0,07% | Hisse senetleri |
| CWA Asset Management Group, LLC | $5.003.575 | 22.490 | 0,06% | Hisse senetleri |
| Legal & General Group Plc | $4.992.452 | 22.440 | 0,06% | Hisse senetleri |
| Mitsubishi UFJ Trust & Banking Corp | $4.942.393 | 22.215 | 0,06% | Hisse senetleri |
Şirket yöneticileri 59 içeriden öğrenenler · 31 yöneticiler · 25 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16 Haziran 2026 S | 840.408 | 0 | 2 | $-14.532.097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17 Mayıs 2016 S | 18.766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 07 Mayıs 2026 S | 132.434 | 0 | 1 | $-9.887.579 |
| Luis Borgen | Chief Financial Officer | 22 Mart 2012 M | 18.517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31 Mart 2010 A | 33.604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14 Mart 2007 A | 31.250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 01 Temmuz 2006 A | 10.000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 12 Mayıs 2026 S | 94.105 | 0 | 2 | $-4.089.696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16 Ağustos 2024 S | 209.365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24 Aralık 2016 A | 4.688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15 Haziran 2026 S | 109.194 | 0 | 2 | $-3.210.360 |
| James O Hearty | Chief Compliance Officer | 14 Mayıs 2026 M | 22.389 | 0 | 2 | $-3.291.616 |
| Christopher Michael Berry | Chief Accounting Officer | 15 Mart 2026 A | 19.640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15 Mart 2023 F | 15.676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18 Eylül 2020 M | 24.590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 01 Haziran 2020 F | 110.462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 02 Haziran 2019 F | 33.125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13 Haziran 2017 M | 3.514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22 Eylül 2015 M | 7.438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 04 Haziran 2015 S | 2.322.928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13 Şubat 2014 M | 8.990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 09 Eylül 2013 A | — | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 02 Ağustos 2013 G | 2.315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29 Şubat 2012 M | 17.491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17 Haziran 2009 M | 5.547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13 Şubat 2009 M | 2.084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11 Ağustos 2008 M | 2.500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 05 Mart 2008 A | — | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16 Temmuz 2007 A | 6.250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 08 Mayıs 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 04 Kasım 2005 M | 42.000 | 0 | 0 | $0 |
| Dennis W Pullin | Yönetim kurulu üyesi | 15 Ağustos 2026 A | 2.949 | 0 | 0 | $0 |
| Gregory J. Moore | Yönetim kurulu üyesi | 15 Ağustos 2026 A | 8.091 | 0 | 0 | $0 |
| Jason M. Hollar | Yönetim kurulu üyesi | 15 Ağustos 2026 A | 6.883 | 0 | 0 | $0 |
| Patricia M Arway | Yönetim kurulu üyesi | 15 Ağustos 2026 A | 27.223 | 0 | 0 | $0 |
| Adam H Schechter | Yönetim kurulu üyesi | 15 Ağustos 2026 A | 5.970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Yönetim kurulu üyesi | 15 Ağustos 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Yönetim kurulu üyesi | 15 Ağustos 2026 A | 9.803 | 0 | 0 | $0 |
| Barbara J Desoer | Yönetim kurulu üyesi | 15 Ağustos 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Yönetim kurulu üyesi | 15 Mayıs 2025 A | 19.982 | 0 | 0 | $0 |
| John M Nehra | Yönetim kurulu üyesi | 15 Mayıs 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Yönetim kurulu üyesi | 15 Mayıs 2023 A | 16.069 | 0 | 0 | $0 |
| Paula A Price | Yönetim kurulu üyesi | 15 Mayıs 2022 A | 1.395 | 0 | 0 | $0 |
| Shawn M Guertin | Yönetim kurulu üyesi | 15 Mayıs 2021 A | 1.105 | 0 | 0 | $0 |
| Pascal Desroches | Yönetim kurulu üyesi | 15 Kasım 2020 A | 8.030 | 0 | 0 | $0 |
| William L Roper | Yönetim kurulu üyesi | 11 Haziran 2020 A | 16.234 | 0 | 0 | $0 |
| Peter T Grauer | Yönetim kurulu üyesi | 11 Haziran 2020 A | 76.204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Yönetim kurulu üyesi | 31 Aralık 2017 A | 10.764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Yönetim kurulu üyesi | 11 Haziran 2012 A | 7.195 | 0 | 0 | $0 |
| Richard C Vaughan | Yönetim kurulu üyesi | 13 Mayıs 2010 A | 6.092 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 başvurular | 13 Şubat 2025 | 45,00% | Değişiklik | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 130 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 4,50% | 217.039 NS | 30 Nisan 2026 | N-PORT |
| AZTD · Tidal Trust I | 2,74% | 7.761 NS | 30 Nisan 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,19% | 123.121 NS | 30 Nisan 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,40% | 59.690 SH | 08 Ağustos 2026 | Günlük |
| AGNG · Global X Funds | 0,92% | 3.855 NS | 31 Mayıs 2026 | N-PORT |
| IHF · iShares Trust | 0,86% | 58.907 SH | 08 Ağustos 2026 | Günlük |
| LSEQ · Harbor ETF Trust | 0,76% | 758 NS | 30 Nisan 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,56% | 5.441 NS | 31 Mayıs 2026 | N-PORT |
| ITAN · EA Series Trust | 0,38% | 1.735 NS | 29 Mayıs 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,38% | 10.626 NS | 30 Nisan 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,34% | 11.220 NS | 31 Mayıs 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9.914 SH | 08 Ağustos 2026 | Günlük |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,30% | 2.502 NS | 31 Mayıs 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 0,30% | 352 NS | 30 Nisan 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,28% | 909.000 PA | 08 Ağustos 2026 | Günlük |
| DFVE · DoubleLine ETF Trust | 0,24% | 425 NS | 31 Mart 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,24% | 22.988 SH | 08 Ağustos 2026 | Günlük |
| IQSM · New York Life Investments ETF Trust | 0,23% | 4.682 NS | 30 Nisan 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,18% | 635 NS | 30 Nisan 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,17% | 934.012 SH | 08 Ağustos 2026 | Günlük |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467.367 SH | 08 Ağustos 2026 | Günlük |
| BKMC · BNY Mellon ETF Trust | 0,14% | 5.728 NS | 30 Nisan 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 1.975 NS | 30 Nisan 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,14% | 124.181 NS | 30 Nisan 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 3.564 NS | 30 Nisan 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,12% | 90.512 NS | 31 Mayıs 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,11% | 100.394 SH | 08 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,11% | 6.082 SH | 08 Ağustos 2026 | Günlük |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 14.233 NS | 30 Nisan 2026 | N-PORT |
| ESML · iShares Trust | 0,10% | 15.995 SH | 08 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,10% | 17.983 NS | 30 Nisan 2026 | N-PORT |
| ISCB · iShares Trust | 0,10% | 1.555 SH | 08 Ağustos 2026 | Günlük |
| IYH · iShares Trust | 0,09% | 19.255 SH | 08 Ağustos 2026 | Günlük |
| RXL · ProShares Trust | 0,09% | 348 NS | 31 Mayıs 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 3.622 SH | 08 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736.199 SH | 08 Ağustos 2026 | Günlük |
| SMMD · iShares Trust | 0,08% | 16.234 SH | 08 Ağustos 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,08% | 3.527 SH | 08 Ağustos 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,07% | 667 NS | 30 Nisan 2026 | N-PORT |
| IXJ · iShares Trust | 0,07% | 16.934 SH | 08 Ağustos 2026 | Günlük |
| SMMV · iShares Trust | 0,07% | 1.125 SH | 08 Ağustos 2026 | Günlük |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,07% | 5.907 NS | 30 Nisan 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,07% | 1.423 NS | 31 Mayıs 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,07% | 930 NS | 29 Mayıs 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,06% | 33.893 SH | 08 Ağustos 2026 | Günlük |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3.136 SH | 08 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,05% | 1.985 SH | 08 Ağustos 2026 | Günlük |
| TILT · FlexShares Trust | 0,05% | 6.930 NS | 30 Nisan 2026 | N-PORT |
| IWS · iShares Trust | 0,05% | 45.847 SH | 08 Ağustos 2026 | Günlük |
| DUHP · Dimensional ETF Trust | 0,04% | 32.462 NS | 30 Nisan 2026 | N-PORT |